Literature DB >> 28545325

Mandibular odontoameloblastoma in a rat and a horse.

Brian Murphy1,2,3, Cynthia Bell1,2,3, Amanda Koehne1,2,3, Richard R Dubielzig1,2,3.   

Abstract

Odontoameloblastoma (OA) is a mixed odontogenic tumor that is an ameloblastoma with concurrent histologic evidence of odontoma differentiation. As a mixed tumor, OA is a tripartite lesion comprised of neoplastic odontogenic epithelium, induced dental ectomesenchyme (dental pulp), and mineralized dental matrix. Although rare, OA represents a diagnostic conundrum, as it is histologically closely related to 2 other mixed odontogenic tumors: odontoma (complex and compound) and ameloblastic fibro-odontoma. Herein we describe an OA arising from the mandible of a 4-mo-old Fischer 344 rat that had been exposed in utero to the mutagen ENU (N-ethyl-N-nitrosourea), and a naturally occurring lesion in a 2-y-old Appaloosa horse. In order to satisfy the diagnostic criteria for this lesion, mineralized dental matrix in relationship to neoplastic odontogenic epithelium must be identifiable within the OA lesion. This group of odontogenic tumors is differentiated by the degree to which the dental matrix is organized and the relative proportions of pulp ectomesenchyme, odontogenic matrix, and odontogenic epithelium.

Entities:  

Keywords:  Equine; horses; mandible; odontoameloblastoma; odontogenic mixed tumor; rats

Mesh:

Year:  2017        PMID: 28545325     DOI: 10.1177/1040638717711996

Source DB:  PubMed          Journal:  J Vet Diagn Invest        ISSN: 1040-6387            Impact factor:   1.279


  2 in total

Review 1.  Ameloblastic carcinoma in horses: case report and literature review.

Authors:  Megan E Schreeg; Megan Radkin; Jennifer Haugland; Brian G Murphy; Steve Rushton; Keith E Linder
Journal:  J Vet Diagn Invest       Date:  2022-01-17       Impact factor: 1.569

2.  Mixed odontogenic tumors in four young dogs: ameloblastic fibroma and ameloblastic fibro-odontoma.

Authors:  Patrick Huang; Cynthia Bell; Vanessa Wallace; Brian G Murphy
Journal:  J Vet Diagn Invest       Date:  2018-11-18       Impact factor: 1.279

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.